TAMPA, Fla., May 12, 2009 (GLOBE NEWSWIRE) -- Kforce Clinical Research Inc., a provider of clinical trial resourcing solutions and a division of Kforce Inc. (Nasdaq:KFRC), has promoted Peg Connelly to vice president of clinical operations. She is responsible for strategic leadership and operational excellence for pharmaceutical client alliances.
Connelly has led the Kforce Pfizer Alliance for Site Management since joining Kforce in July 2007. Under her leadership, Kforce was awarded the Pfizer 2008 Strategic Supplier Award. She has more than 17 years of industry experience in regional site management operations, study and data management, operational excellence skills and in-depth work across numerous therapeutic areas.
Prior to joining Kforce Clinical Research, Connelly worked for Pfizer in multiple positions, receiving Pfizer's Manager of the Year award in 2004. Connelly is a registered nurse and holds a bachelor's degree in human services from New Hampshire College.
Kforce Clinical Research provides flexible functional outsourcing solutions to the biopharmaceutical industry. It specializes in clinical monitoring, site and study management, drug safety, clinical data management, data entry, clinical programming and biostatistics for Phases I-IV clinical trials.
About Kforce
Kforce (Nasdaq:KFRC) is a professional staffing firm providing flexible and permanent staffing solutions in the skill areas of technology, finance & accounting, health and life sciences, and government solutions (KGS). Backed by approximately 2,000 staffing specialists, Kforce is committed to "Great People = Great Results" for our valued clients and candidates. Kforce operates with 61 offices in 41 markets in North America and two in the Philippines. For more information, please visit our Web site at http://www.kforce.com/.
The Kforce Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3749
Certain of the above statements contained in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended. Factors that could cause actual results to differ materially include the following: business conditions and growth in the staffing industry and general economy; competitive factors, risks due to shifts in the market demand, including, without limitation, shifts in demand for our Technology, Finance and Accounting, Health and Life Sciences and Government Solutions segments, as well as the market for search and flexible staffing assignments; changes in the service mix; ability of the Firm to complete acquisitions; and the risk factors listed from time to time in the Firm's reports filed with the Securities and Exchange Commission, as well as assumptions regarding the foregoing. The words "should," "believe," "estimate," "expect," "intend," "anticipate," "foresee," "plan" and similar expressions and variations thereof identify certain of such forward-looking statements, which speak only as of the dates on which they were made. The Firm undertakes no obligation to publicly update or revise any forward-looking statements. As a result, such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and actual results may differ materially from those indicated in the forward-looking statements as a result of various factors. Readers are cautioned not to place undue reliance on these forward-looking statements.
CONTACT: Kforce Inc.
Michael Blackman, Senior Vice President - Investor Relations
(813) 552-2927
